1729 related articles for article (PubMed ID: 15833296)
1. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
Pichini S; Pujadas M; Marchei E; Pellegrini M; Fiz J; Pacifici R; Zuccaro P; Farré M; de la Torre R
J Pharm Biomed Anal; 2008 Jun; 47(2):335-42. PubMed ID: 18262381
[TBL] [Abstract][Full Text] [Related]
3. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.
Staack RF; Fritschi G; Maurer HH
J Mass Spectrom; 2003 Sep; 38(9):971-81. PubMed ID: 14505325
[TBL] [Abstract][Full Text] [Related]
4. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.
Vorce SP; Holler JM; Levine B; Past MR
J Anal Toxicol; 2008; 32(6):444-50. PubMed ID: 18652752
[TBL] [Abstract][Full Text] [Related]
5. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry.
Gottardo R; Bortolotti F; De Paoli G; Pascali JP; Miksík I; Tagliaro F
J Chromatogr A; 2007 Aug; 1159(1-2):185-9. PubMed ID: 17240388
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
Maresová V; Chadt J; Prikryl L
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
[TBL] [Abstract][Full Text] [Related]
7. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
Peters FT; Schaefer S; Staack RF; Kraemer T; Maurer HH
J Mass Spectrom; 2003 Jun; 38(6):659-76. PubMed ID: 12827635
[TBL] [Abstract][Full Text] [Related]
8. LC-MS analysis of trimethoxyamphetamine designer drugs (TMA series) from urine samples.
Nieddu M; Boatto G; Pirisi MA; Azara E; Marchetti M
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):126-30. PubMed ID: 18417429
[TBL] [Abstract][Full Text] [Related]
9. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
[TBL] [Abstract][Full Text] [Related]
10. Determination of estrogens and progestogens by mass spectrometric techniques (GC/MS, LC/MS and LC/MS/MS).
Díaz-Cruz MS; López de Alda MJ; López R; Barceló D
J Mass Spectrom; 2003 Sep; 38(9):917-23. PubMed ID: 14505318
[TBL] [Abstract][Full Text] [Related]
11. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis.
Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and the urinary excretion profile of the recently scheduled designer drug N-Benzylpiperazine (BZP) in the rat.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nakajima K; Inoue H; Kishi T; Tsuchihashi H
J Anal Toxicol; 2006; 30(1):38-43. PubMed ID: 16620530
[TBL] [Abstract][Full Text] [Related]
13. Isolation, identification and excretion profile of the principal urinary metabolite of the recently banned designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP) in rats.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nakajima K; Inoue H; Kishi T; Tsuchihashi H
Xenobiotica; 2005 Jan; 35(1):107-16. PubMed ID: 15788372
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of oxysophocarpine and its active metabolite sophocarpine in rat plasma by liquid chromatography/mass spectrometry for a pharmacokinetic study.
Wang SJ; Yang M; Li XT; Wang GJ
Biomed Chromatogr; 2007 Jul; 21(7):768-74. PubMed ID: 17428011
[TBL] [Abstract][Full Text] [Related]
15. Combination of liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry for the detection of 21 anabolic steroid residues in bovine urine.
Van Poucke C; Van De Velde M; Van Peteghem C
J Mass Spectrom; 2005 Jun; 40(6):731-8. PubMed ID: 15782394
[TBL] [Abstract][Full Text] [Related]
16. Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans.
Antia U; Tingle MD; Russell BR
J Forensic Sci; 2010 Sep; 55(5):1311-8. PubMed ID: 20533987
[TBL] [Abstract][Full Text] [Related]
17. Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization.
Teixeira H; Verstraete A; Proença P; Corte-Real F; Monsanto P; Vieira DN
Forensic Sci Int; 2007 Aug; 170(2-3):148-55. PubMed ID: 17614225
[TBL] [Abstract][Full Text] [Related]
18. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids.
Georgakopoulos CG; Vonaparti A; Stamou M; Kiousi P; Lyris E; Angelis YS; Tsoupras G; Wuest B; Nielen MW; Panderi I; Koupparis M
Rapid Commun Mass Spectrom; 2007; 21(15):2439-46. PubMed ID: 17610244
[TBL] [Abstract][Full Text] [Related]
19. High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.
Liu W; Cai HL; Li HD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):405-11. PubMed ID: 17222591
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
Juan H; Zhiling Z; Huande L
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):33-9. PubMed ID: 15866490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
